Recorded fact · drug.label_indication
drug.label_indication for sarilumab|rheumatoid-arthritis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 2ad7697a resolves to.
The record
| Fact id | 2ad7697ad1a53fe6d6b2ba1e |
|---|---|
| Entity | drug: sarilumab|rheumatoid-arthritis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260227 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).
Shown with dashes as hyphens. SHA-256 of the exact stored quote: c28f6294b67d2d838d84239381244e716ab08f9281e0591f78a7ff69ecf7c564.
The value
{
"ingredient": "Sarilumab",
"conditionId": "rheumatoid-arthritis",
"conditionName": "Rheumatoid arthritis",
"matchedAlias": "rheumatoid arthritis",
"context": "indication",
"brand": "KEVZARA",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "827bc01c-d379-4266-a18c-c7f904b76af3",
"labelEffectiveTime": "20260227",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: d68d691e365c86c3bdca4149fcbe8cc4132b307a96dd164566abca4c178a627b.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.